MedPath

Empowerment and Support for the Diabetic Patient

Not Applicable
Conditions
Type 2 Diabetes
Interventions
Behavioral: Health Coaching
Registration Number
NCT02179385
Lead Sponsor
Clalit Health Services
Brief Summary

CHANGE-D objectives are to evaluate to what extent personal coaching for healthy lifestyle and treatment adherence improves clinical outcomes among uncontrolled diabetic patients.

Evaluate to what extent personal coaching for healthy lifestyle and treatment adherence improves self treatment among uncontrolled diabetic patients.

Detailed Description

Research Group 300 type 2 diabetics: 150 from Jewish sector and 150 from Arab sector will be recruited from 7-10 clinics in each district: North District and Haifa District A personal coaching intervention will be tailored from the offered tools: Face to face, group, telephone Participants will be monitored for clinical and self treatments outcomes Comparison Group 300 patients with similar characteristics to the research group will receive Clalit's standard of care Participants will be monitored for clinical and self treatments outcomes like the research group

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Type 2 diabetes
  • At least one oral anti diabetic drug
  • HbA1c above 7.5% ot above 0.5% of personal target
  • Preparedness for change
  • Fluent Hebrew or Arabic
Exclusion Criteria
  • Type 1 diabetes
  • Pregnancy or lactation
  • Incompetency to sign consent
  • Participation in another clinical trial
  • Unstable psychotic disease
  • Complex health condition

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Health coachingHealth CoachingPatients receive health coaching via the phone, face to face or group support, according to patients' choice
Primary Outcome Measures
NameTimeMethod
Clinical composite0, 6, 12, 18 months from randomization

Change from baseline in a composite endpoint of HbA1c, BMI, Blood Pressure, Lipids at 6, 12 and 18 months from randomization

Secondary Outcome Measures
NameTimeMethod
Change in Self Treatment Score0, 6, 12, 18 months from randomization

Change from baseline in Self treatment diabetes questionnaire score at 6, 12 and 18 months from randomization

Change in Self Efficacy Score0, 6, 12, 18 months from randomization

Change from baseline in Self Efficacy questionnaire score at 6, 12 and 18 months from randomization

© Copyright 2025. All Rights Reserved by MedPath